Rajasthan Antibiotics is an API manufacturer based in India. It holds 3 active US drug master files across a filed portfolio of 4 molecules. Customs aggregates show $12.5M of exports covering 284 molecules to 16 destinations in 2025.
| Site | FDA FEI |
|---|---|
| ALWAR, India | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Acyclovir | SFDA (Saudi Arabia), US FDA | 2 |
| Meropenem | US FDA | 1 |
| Pantoprazole | SFDA (Saudi Arabia) | 1 |
| Piperacillin | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 2 | None |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $1.8M | 7 |
| 2025 | Not reported | $12.5M | 16 |
| 2024 | Not reported | $10.8M | 14 |
| 2023 | Not reported | $8.4M | 14 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Rajasthan Antibiotics comes back tiered against every other supplier able to file there.
Start for free